LUPPI, MARIO
LUPPI, MARIO
Universita' degli Studi di MILANO
Myeloablative conditioning with thiotepa-busulfan-fludarabine does not improve the outcome of patients transplanted with active leukemia: final results of the GITMO prospective trial GANDALF-01
2022 F. Bonifazi, C. Pavoni, J. Peccatori, F. Giglio, M. Arpinati, A. Busca, P. Bernasconi, A. Grassi, A. Paola Iori, F. Patriarca, L. Brunello, C. Di Grazia, A. Michele Carella, D. Cilloni, A. Picardi, A. Proia, S. Santarone, R. Sorasio, P. Carluccio, P. Chiusolo, A. Cupri, M. Luppi, C. Nozzoli, D. Baronciani, M. Casini, G. Grillo, M. Musso, F. Onida, G. Palazzo, M. Parma, S. Tringali, A. Vacca, D. Vallisa, N. Sacchi, E. Oldani, A. Masciulli, A. Gheorghiu, C. Girmenia, M. Martino, B. Bruno, A. Rambaldi, F. Ciceri
Neutralizing monoclonal antibodies in haematological patients paucisymptomatic for COVID-19: The GIMEMA EMATO-0321 study
2022 V. Marasco, A. Piciocchi, A. Candoni, L. Pagano, A. Guidetti, P. Musto, R. Bruna, M. Bocchia, A. Visentin, M. Turrini, A. Tucci, S. Pilerci, L. Fianchi, M. Salvini, S. Galimberti, E. Coviello, C. Selleri, M. Luppi, E. Crea, P. Fazi, F. Passamonti, P. Corradini
| Titolo | Data di pubblicazione | Autori | Tipo | File | Abstract |
|---|---|---|---|---|---|
| Myeloablative conditioning with thiotepa-busulfan-fludarabine does not improve the outcome of patients transplanted with active leukemia: final results of the GITMO prospective trial GANDALF-01 | 1-giu-2022 | Mario LuppiFrancesco OnidaAlessandro Rambaldi + | Article (author) | - | |
| Neutralizing monoclonal antibodies in haematological patients paucisymptomatic for COVID-19: The GIMEMA EMATO-0321 study | 1-ott-2022 | Marasco, VincenzoGuidetti, AnnaTurrini, MauroTucci, AlessandraLuppi, MarioCorradini, Paolo + | Article (author) | - |